1. Home
  2. RYTM vs MWH Comparison

RYTM vs MWH Comparison

Compare RYTM & MWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

N/A

Current Price

$97.07

Market Cap

5.8B

Sector

Health Care

ML Signal

N/A

Logo SOLV Energy Inc. Class A Common Stock

MWH

SOLV Energy Inc. Class A Common Stock

N/A

Current Price

$25.47

Market Cap

5.1B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
RYTM
MWH
Founded
2008
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.1B
IPO Year
2017
2026

Fundamental Metrics

Financial Performance
Metric
RYTM
MWH
Price
$97.07
$25.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
12
Target Price
$131.14
$35.42
AVG Volume (30 Days)
421.1K
1.7M
Earning Date
05-05-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
28.34
N/A
EPS
N/A
0.11
Revenue
N/A
N/A
Revenue This Year
$55.34
$51.86
Revenue Next Year
$86.06
$14.78
P/E Ratio
N/A
$236.36
Revenue Growth
N/A
N/A
52 Week Low
$74.50
$23.83
52 Week High
$122.20
$48.40

Technical Indicators

Market Signals
Indicator
RYTM
MWH
Relative Strength Index (RSI) 40.64 41.31
Support Level $99.14 $23.88
Resistance Level $113.04 $30.74
Average True Range (ATR) 3.98 1.27
MACD -0.78 -0.07
Stochastic Oscillator 19.75 26.04

Price Performance

Historical Comparison
RYTM
MWH

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

About MWH SOLV Energy Inc. Class A Common Stock

SOLV Energy Inc is a provider of infrastructure services to the power industry, including engineering, procurement, construction, testing, commissioning, operations, maintenance and repowering. It specializes in designing, building and maintaining utility-scale solar and battery storage projects and related T&D infrastructure. The company's projects include: The Eldorado Solar Project, Gravel Pit Solar Project, and Vikings Solar-plus-Storage Project. It operates in one reportable segment which derives revenue through providing EPC, O&M and Development services throughout the Unites Sates. The company derives maximum of revenue from its EPC contracts.

Share on Social Networks: